Federica V. Conti

Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Off-label prescribing in ophthalmology: a retrospective analysis.

Off-label prescribing in ophthalmology: a retrospective analysis.

Journal: Frontiers in pharmacology

Published: March 23, 2026

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Journal: Inflammation

Published: November 06, 2025

Safety profile of lutein-based blue dyes and surgical lights.

Safety profile of lutein-based blue dyes and surgical lights.

Journal: Frontiers in pharmacology

Published: September 12, 2025

Development of a novel NIR spectroscopy-based chemometric model for sourdough bread authentication.

Development of a novel NIR spectroscopy-based chemometric model for sourdough bread authentication.

Journal: Food chemistry

Published: May 12, 2025

Phytochemical Analysis and Biological Activities of Wollemia nobilis W.G.Jones, K.D.Hill & J.M.Allen Leaves Collected in the Botanical Garden of Rome.

Phytochemical Analysis and Biological Activities of Wollemia nobilis W.G.Jones, K.D.Hill & J.M.Allen Leaves Collected in the Botanical Garden of Rome.

Journal: Plants (Basel, Switzerland)

Published: March 20, 2025

Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate.

Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate.

Journal: Frontiers in pharmacology

Published: December 19, 2024

α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells.

α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells.

Journal: International journal of molecular sciences

Published: December 16, 2024

Retinal Protection of New Nutraceutical Formulation.

Retinal Protection of New Nutraceutical Formulation.

Journal: Pharmaceutics

Published: November 25, 2024

From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies.

From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies.

Journal: Molecular pharmaceutics

Published: November 08, 2024

Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity.

Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity.

Journal: European journal of pharmacology

Published: September 11, 2024

Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy.

Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy.

Journal: British journal of pharmacology

Published: July 31, 2024

The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach.

The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 19, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026